BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15967786)

  • 1. Targeting antigen to CD19 on B cells efficiently activates T cells.
    Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
    Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells.
    Brown SL; Barrault DV; Phythian-Adams A; Knight AM
    Int Immunol; 2006 Jan; 18(1):69-78. PubMed ID: 16291653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
    Sato S; Miller AS; Howard MC; Tedder TF
    J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
    Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
    Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19 regulates B lymphocyte responses to transmembrane signals.
    Fujimoto M; Poe JC; Inaoki M; Tedder TF
    Semin Immunol; 1998 Aug; 10(4):267-77. PubMed ID: 9695183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19.
    Taylor DK; Ito E; Thorn M; Sundar K; Tedder T; Spatz LA
    Mol Immunol; 2006 Apr; 43(11):1776-90. PubMed ID: 16430962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
    Wu HY; Monsonego A; Weiner HL
    J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement's participation in acquired immunity.
    Nielsen CH; Leslie RG
    J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
    Kowolik CM; Topp MS; Gonzalez S; Pfeiffer T; Olivares S; Gonzalez N; Smith DD; Forman SJ; Jensen MC; Cooper LJ
    Cancer Res; 2006 Nov; 66(22):10995-1004. PubMed ID: 17108138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation and transfer between B cells and macrophages.
    Harvey BP; Gee RJ; Haberman AM; Shlomchik MJ; Mamula MJ
    Eur J Immunol; 2007 Jul; 37(7):1739-51. PubMed ID: 17534863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
    Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
    J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycan isolated from Phellinus linteus activates murine B lymphocytes via protein kinase C and protein tyrosine kinase.
    Kim GY; Park SK; Lee MK; Lee SH; Oh YH; Kwak JY; Yoon S; Lee JD; Park YM
    Int Immunopharmacol; 2003 Sep; 3(9):1281-92. PubMed ID: 12890426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.